Optos is inviting Australian eyecare professionals to take part in a free CPD-accredited webinar focussing on autofluorescence and retinal diseases.
Mr Simon Browning, a qualified optometrist who has owned a private practice and served on the national councils of the College of Optometrists and the Association of Optometrists in the UK, will host the session on Tuesday 20 July from 7.30pm to 8.45pm (AEST). It is open to both optometrists and ophthalmologists.
According to Optos, expanding clinical applications make autofluorescence an essential tool for evaluating age-related macular degeneration, macular dystrophies and many other retinal disorders.
During the webinar, Browning – the world’s first to use the Optos Daytona autofluorescent imaging system in practice – will describe the use of autofluorescence to detect abnormalities beyond those identified on funduscopic exams, fluorescein angiography, or OCT. This will include its role to elucidate disease pathogenesis, form genotype-phenotype correlations, diagnose and monitor disease, and evaluate novel therapies.
Browning’s presentation will also highlight the rationale behind routine retinal autofluorescence imaging, the retinal pigment epithelium structure and metabolic activity, differentiation and interpretation of hyper and hypofluorescent images, and decision-making after examining autofluorescent images.
The free webinar is CPD-approved by Optometry Australia’s Institute of Excellence, with one CPD hour on offer.
Browning has lectured widely through Europe and the US. He has presented posters on regression of drusen in macular degeneration at both Association for Research in Vision and Ophthalmology (ARVO) and European Academy of Optometry and Optics (EAOO) conferences. His company Browning Consulting delivers university, large venue and ‘in practice’ one-to-one training in the use of ultra-widefield imaging systems.
When: Tuesday, 20 July, 2021
Time: 7:30pm to 8:45pm AEST.
Where: Online. Click here to register.